Clinical trial
Efficacy of Deutetrabenazine in Huntington's Disease Patients with Dysphagia: a Randomised, Placebo-controlled Pilot Study
NCT04301726 is registered in ClinicalTrials.gov with Fundacion Huntington Puerto Rico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Deutetrabenazine in Huntington's Disease Patients with Dysphagia: a Randomised, Placebo-controlled Pilot Study
- Lead sponsor
- Fundacion Huntington Puerto Rico
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- January 21, 2022
- Completion date
- September 1, 2023
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.